AXO Racing Suit, Worn and Signed by 2016 Motard Champion Andrea Occhini

关闭

Ended:Thursday 28 December EST 2017 于 12:10

Winner: Sisasisa

€230($251 USD)

慈善百分比

85%

错过了？

另一个独特的物品可能就在您身边！

联系我们

慈善百分比

85%

奖品

Take home this fabulous, red AXO racing suit worn by the Italian motorcycle driver Andrea Occhini during the 2016 Italian Motard Championship.

Born in Codogno, Italy on December 15, 1986, Occhini triumphed in that championship.

The race suit presents signs of use and wear, caused by a fall during the Italian race.

Andrea Occhini has even autographed the suit and added the phrase: "1° Classificato campionato Supermoto S1 2016" (1st Ranking 2016 Supermoto S1 Championship).

Features:

Red AXO racing suit
Autographed

通过拍卖方式购买独特的物品前还需要买家的仔细评估。我们邀请您在购买之前查看您所掌握的所有信息和资料，包括我们的退货政策。

原因

Fondazione Telethon is a third-sector organization that has been working since 1990 to advance scientific research toward curing rare genetic diseases. It does this by supporting and implementing the best possible research: from basic research, which is necessary to understand disease mechanisms and identify new therapies, to clinical research, which involves patients. It is a great collective endeavor that feeds on the support of civil society and supporters and has repeatedly generated concrete impacts on patients' lives.

For the Telethon Foundation's mission to be fully accomplished, however, scientific results, however positive, are not enough: the therapies developed must actually be available to patients. Instead, access to treatment is increasingly compromised, particularly for advanced therapies such as gene therapies. In the face of inevitable abandonment of the field by the pharmaceutical industry, there is a risk that patients will no longer have access to life-saving therapies.

This is what happened in 2022 with the two gene therapies developed by the San Raffaele Telethon Institute for Gene Therapy in Milan for two severe congenital immunodeficiencies-Ada-Scid and Wiskott-Aldrich syndrome. Children with these diseases have been and are at risk of not being able to benefit from these therapies-an unacceptable situation for the Telethon Foundation, which decided to correct it by taking responsibility for producing and distributing them. A commitment compl

网站